Tasigna (Nilotinib) Therapy for Parkinson’s Disease is Not Ready for Use in Patients
Cancer drug is not ready for broad clinical use in Parkinson's http://parkinson.org/our-impact/press-room/press-releases/should-patients-and-families-be-considering-tasigna-nilotinib-therapy-for-parkinsons
To read more books and articles by Michael S. Okun MD check Twitter @MichaelOkun and these websites with blogs and information on his books and http://parkinsonsecrets.com/ #EndingPD and https://www.tourettetreatment.com/